New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure

New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure

1. Discuss the role of nonsteroidal mineralocorticoid receptor antagonists (ns-MRAs) in mitigating cardiac fibrosis and inflammation 2. Assess benefit-risk profiles of ns-MRAs in reducing morbidity and mortality in patients with symptomatic heart failure 3. Implement evidence-based treatment and monitoring strategies for use of ns-MRAs when managing patients to reduce cardiovascular morbidity and mortality

  • Provider:Global Learning Collaborative
  • Activity Link: https://pace-cme.org/
  • Start Date: 2024-10-18 05:00:00
  • End Date: 2024-10-18 05:00:00
  • Credit Details: AAPA Category 1 Credit™️: 0.5 hours
    AMA PRA Category 1 Credit™️: 0.5 hours
    Nursing: 0.5 hours
    Pharmacy: 0.5 hours
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.